All Pharma News
Khondrion announces grant of patents in the US and Europe for sonlicromanol

Khondrion announces grant of patents in the US and Europe for sonlicromanol
PR NEWSWIRE
01 Nov 2023
Share Share
Khondrion announces sonlicromanol Phase IIb progress

Khondrion announces sonlicromanol Phase IIb progress
GLOBENEWSWIRE
22 Nov 2022
Share Share
Khondrion forges on despite phase 2 mitochondrial disease fail

Khondrion forges on despite phase 2 mitochondrial disease fail
Nick Paul Taylor FIERCEBIOTECH
22 Nov 2022
Share Share
Khondrion completes enrolment in Phase IIb trial evaluating sonlicromanol

Khondrion completes enrolment in Phase IIb trial evaluating sonlicromanol
GLOBENEWSWIRE
10 Jan 2022
Share Share
Khondrion moves headquarters to Novio Tech Campus to support growth

Khondrion moves headquarters to Novio Tech Campus to support growth
PRESS RELEASE
26 Aug 2021
Share Share
Khondrion announces first patients dosed in 6-month paediatric Phase II study

Khondrion announces first patients dosed in 6-month paediatric Phase II study
GLOBENEWSWIRE
21 Apr 2021
Share Share
Khondrion, the clinical-stage pharmaceutical company discovering

Khondrion, the clinical-stage pharmaceutical company discovering
KHONDRION
06 Apr 2021
Share Share
Khondrion receives EMA agreement on its Paediatric Plan for sonlicromanol

Khondrion receives EMA agreement on its Paediatric Plan for sonlicromanol
GLOBENEWSWIRE
18 Jan 2021
Share Share
Khondrion announces publication in Scientific Reports outlining

Khondrion announces publication in Scientific Reports outlining
PHARMIWEB
13 Jan 2021
Share Share
Khondrion shares progress of sonlicromanol development at Mitochondrial

Khondrion shares progress of sonlicromanol development at Mitochondrial
PHARMIWEB
30 Nov 2020
Share Share